نتائج البحث

Infectious diseases. Doubts dispelled about HIV prevention.

• Authors : Cohen J

Subjects: Pre-Exposure Prophylaxis*; Anti-Retroviral Agents/Anti-Retroviral Agents/Anti-Retroviral Agents/*administration & dosage ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives

• Source: Science (New York, N.Y.) [Science] 2015 Mar 06; Vol. 347 (6226), pp. 1055-6.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

تفاصيل العنوان

Miriam Hospital launches new HIV prevention program: PrEP program offers daily pill that can help prevent HIV infection.

Subjects: Hospitals* ; Pre-Exposure Prophylaxis*; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives

• Source: Rhode Island medical journal (2013) [R I Med J (2013)] 2014 Jan; Vol. 97 (1), pp. 57.Publisher: Rhode Island Medical Society Country of Publication: United States NLM ID: 101605827 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

PrEP trial successes prompt cost-effectiveness questions.

• Authors : Khamsi R

Subjects: Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*prevention & control ; Cost-Benefit Analysis/Cost-Benefit Analysis/Cost-Benefit Analysis/*statistics & numerical data ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives

• Source: Nature medicine [Nat Med] 2011 Sep 07; Vol. 17 (9), pp. 1028. Date of Electronic Publication: 2011 Sep 07.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

AIDS research. Complexity surrounds HIV prevention advances.

• Authors : Cohen J

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; HIV Infections/HIV Infections/HIV Infections/*prevention & control

• Source: Science (New York, N.Y.) [Science] 2011 Jul 22; Vol. 333 (6041), pp. 393.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

تفاصيل العنوان

HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.

• Authors : Cohen J

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; HIV Infections/HIV Infections/HIV Infections/*prevention & control

• Source: Science (New York, N.Y.) [Science] 2010 Dec 03; Vol. 330 (6009), pp. 1298-9.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

تفاصيل العنوان

AIDS research. FDA panel recommends anti-HIV drug for prevention.

• Authors : Cohen J

Subjects: Drug Approval* ; United States Food and Drug Administration*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use

• Source: Science (New York, N.Y.) [Science] 2012 May 18; Vol. 336 (6083), pp. 792.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

تفاصيل العنوان

Trial success spurs planning for rollout of HIV prevention pills.

• Authors : Dolgin E

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; HIV Infections/HIV Infections/HIV Infections/*prevention & control

• Source: Nature medicine [Nat Med] 2011 Apr; Vol. 17 (4), pp. 392.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Xeloda. Warning: drug interaction increase bleeding risks.

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*adverse effects ; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*adverse effects

• Source: Nursing [Nursing] 2002 Mar; Vol. 32 (3), pp. 26.Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7600137 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

Drug combination approved for advanced breast cancer.

Subjects: Taxoids*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

• Source: FDA consumer [FDA Consum] 2002 Jan-Feb; Vol. 36 (1), pp. 5.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

HIV study yields unexpected preliminary efficacy results.

• Authors : Traynor K

Subjects: Anti-Retroviral Agents/Anti-Retroviral Agents/Anti-Retroviral Agents/*therapeutic use ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2008 Apr 15; Vol. 65 (8), pp. 686-8.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان